1 / 44

Brucellosis

Brucellosis. M.Karimi. Etiology. Brucella: Abortus(Cattle),Melitensis (Sheep,Goat)Suis(Swin),Canis(Dog) G- Coccobacil Aerobic, Non-spore forming Non motile Blood or Choclate agar. Epidemiology. Unpasteurized milk Occupational events. Inoculation in skin ,Eye

shamira
Download Presentation

Brucellosis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Brucellosis M.Karimi

  2. Etiology • Brucella: Abortus(Cattle),Melitensis (Sheep,Goat)Suis(Swin),Canis(Dog) • G- Coccobacil • Aerobic, Non-spore forming • Non motile • Blood or Choclate agar

  3. Epidemiology • Unpasteurized milk • Occupational events

  4. Inoculation in skin ,Eye (Through abrasion or conjunctiva) Inhalation (Infected aerosol) Ingestion (Meat, Dairy products) Risk of infection depends Nutritional status Immune status Rout of inoculum Species of brucella Pathogenesis

  5. Pathogenesis • Survive& Replicate within phagocytes&Monocytes • Infected macrophages localized within reticuloendothelial system(Granuloma formation in spleen,liver,bone marrow)

  6. + History of animal or food exposure Acute or insidious symptoms(2-4 wk after inoculation) Refusal to eat Refusal to bear weight Lassitude FTT Headache Inattention/Depression Abdominal pain Headache Diarrhea Rash Night sweets Weakness Fatigue Cough Vomiting Pharyngitis Clinical manifestationTriad: Fever, Arthralgia/Arthritis,Hepatosplenomegaly

  7. Fever • Hepatosplenomegally • Arthralgia/Arthritis Sacroiliac,Hip,Ankle,

  8. Diagnosis • WBC Normal or low • + History of animal or food exposure • Recovering organisms (blood’ bone marrow’..) • Serum agglutination test: >1/160 (Antibody against Abortus ,Melitensis, Suis, but not Canis) • 2ME

  9. Differential diagnosis • Car-Scratch disease • Typhoid fever • TB • Fungal infections

  10. > or = 9 years old 1- Doxycycline 200 mg/D PO 6 WK + Streptomycin 1 g/D IM 1-2 WK OR Gentamycin 3-5 mg/kg/d IM/IV 1-2 WK -------------------------------------------------- 2- Doxycycline 200 mg/D PO 6 WK + Rifampin 600-900 mg/D PO 6 WK < 9 years old TMP-SMZ: po 45 days (TMP 10 mg/Kg/D) (SMZ 50 mg/KG/D) + Rifampin 15-20 mg/kg/D PO 45 days Treatment

  11. Salmonellae Infections M.Karimi

  12. Etiology Salmonellae (G- ‘Facultative’Bacilli) • Antigens: Flagellum(H)’ Cell wall(O)’ Envelope(Vi) • Serogroups on the basis of O antigen: A’ B’ C1’ C2’ D’ E • Serotypes: S.Typhi’ S.Paratyphi’…. • Transmission: Water’ Food(beef’poultry’milk’egg’..)

  13. Salmonella Gastroentritis (Nontyphoidal) Epidemiology • Age: <4 y/o (< 1y/o) • Source of infection: Poultry’eggs’ egg product ’meats’ • Transmission: Carrier (Human) • Incubation period: 6-72 hr. (usually less than 24 hr.) • Peak incidence: Late summer &Early fall

  14. Pathogenesis • Ingestion • Attached to “M” cells • Phagocytosed by macrophages • Replication • Bacteremia

  15. Clinical manifestations • Self limited diseases: 3-7 days • Onset: Abrupt • Nausea’ Vomiting’ Crampy abdominal pain • Loose watery stool • Malaise’ headache’ chills • Fever 38-38.9 c (70%) for 48 hour

  16. Complications • Dehydration’Shock • Localized infection: Pneumonia Empyema Abscesses Osteomyelitis Septic arthritis Postinfectious arthritis Pyelonephritis meningitis

  17. Diagnosis • Cultures (Stool’ Blood’ Urine’ Bone marrow’ CSF’…)

  18. Treatment • Correction of shock’ dehydration’… • Antibiotics: 1-Infants < 3 mo. 2-Child with immunodeficiency’ Malnutrition Malignancy’ Intravascular catheter or other foreign material

  19. Treatment • Ceftriaxone or Cefotaxime Septicemia’ Enteric fever’ Metastatic site of infection • Amoxicillin • Co-trimaxozole • Fluroqinolones • Chloramphenicol

  20. Typhoid fever

  21. Clinical manifestation • Infant: mild GE to severe septicemia without diarrhea Fever’ hepatomegaly ’ jaundice’ anorexia’ lethargy’ weight loss • Child: High fever’ malaise ’lethargy’ myalgia’ headache’ rash’ Hepatomegaly’ abdominal pain and tenderness’ diarrhea(50%)’ constipation obtunded ’delirium’ confusion ’splenomegaly’ Macular (Rose spot) or Maculopapolar rash(30%) High T with low PR (Typically each 1 degree above 38.3° C Rise PR 10/min)

  22. Intestinal perforation(0.5-3%) Severe GI hemorrhage(1-10%) Toxic encephalopathy Cerebral thrombosis Acute cerebral ataxia Aphasia Optic neuritis Deafness Transverse myelitis Acute cholecystitis Pneumonia Pyelonephritic Endocarditis Meningitis Osteomyelitis Septic arthritis Complications

  23. Diagnosis Cultures: Blood’ Urine’ Stool’ Bone marrow’ Lymph nodes’ Deudenal fluied’ Reticuloendothelial tissue’ Differential diagnosis Bronchitis Bronchopneumonia Gastroenteritis Influenza Diagnosis & Differential diagnosis

  24. Drugs: Ceftriaxone Ampicillin Chloramphenicol Co-Trimoxozole Ciprofloxacin Azithromycin Surgery Cholecystectomy Treatment

  25. Prognosis • With treatment : Mortality <1% • Without treatment : Relapse up to 10% • Chronic carrier: Excrete S.typhi for more than 3 mo.

  26. Diphtheria • Diphtheria is an acute toxic infection caused by Corynebacterium species, typically Corynebacterium diphtheriae .

  27. Corynebacteria Aerobic, nonencapsulated, non-spore- forming, mostly nonmotile, pleomorphic, gram-positive bacilli

  28. EPIDEMIOLOGY • Spread: • airborne respiratory droplets • direct contact • Asymptomatic respiratory tract carriage is important in transmission. • Skin infection and skin carriage • contaminated milk • infected food handler

  29. Clinical manifestation • Paralysis of the palate and hypopharynx is an early local effect of diphtheritic toxin. • Toxin absorption can lead to systemic manifestations: kidney tubule necrosis, thrombocytopenia, cardiomyopathy, and/or demyelination of nerves

  30. serosanguineous, purulent, erosive rhinitis • Shallow ulceration of the external nares and upper lip • sore throat, fever,Dysphagia,Hoarseness • Malaise,Headache,unilateral or bilateral tonsillar membrane formation • enlarged lymph nodes can cause a bull-neck appearance

  31. DIAGNOSIS: culture • COMPLICATIONS: Toxic Cardiomyopathy Toxic Neuropathy • TREATMENT: Antitoxin penicillins, erythromycin

  32. Tetanus • acute, spastic paralytic illness • Clostridium tetani :motile, gram-positive, spore-forming obligate anaerobe • Neurotoxin

  33. EPIDEMIOLOGY • The most common form, neonatal (or umbilical) tetanus • maternal tetanus :postpartum, postabortal, or postsurgical wound infection • traumatic injury • contaminated suture • intramuscular injection • animal bites • abscesses (including dental abscesses) • chronic skin ulceration • Burns • compound fractures, • frostbite, gangrene, intestinal surgery

  34. CLINICAL MANIFESTATIONS • trismus • generalized tetanus • sardonic smile of tetanus (risus sardonicus)

  35. opisthotonos

  36. CLINICAL MANIFESTATIONS • painful spasms of the muscles adjacent to the wound site • Cephalic tetanus : retracted eyelids, deviated gaze, trismus, risus sardonicus, and spastic paralysis of the tongue and pharyngeal musculature

  37. DIAGNOSIS • clinically unimmunized patient (and/or mother) who was injured or born within the preceding 2 wk, who presents with trismus, other rigid muscles • Routine laboratory studies are usually normal

  38. TREATMENT • Surgical wound excision and debridement • human tetanus immunoglobulin (TIG) • Penicillin G • muscle relaxants(Diazepam)

  39. † For children <7 yr of age, DTaP is preferred to tetanus toxoid alone if <3 doses of DTaP have been previously given. If per-tussis vaccine is contraindicated, DT is given. For persons ≥7 yr of age, Td (or Tdap for adolescents 11–18 yr of age) is preferred to tetanus toxoid alone. Tdap is preferred to Td for adolescents 11–18 yr of age who have never received Tdap. Td is preferred to tetanus toxoid for adolescents who received Tdap previously or when Tdap is not available.‡ TIG should be administered for tetanus-prone wounds in HIV-infected patients regardless of the history of tetanus immunizations. § Yes, if ≥10 yr since the last tetanus toxoid-containing vaccine dose.‖ Yes, if ≥5 yr since the last tetanus toxoid-containing vaccine dose CLEAN, MINOR WOUNDS OTHER WOUNDS[*]

More Related